| UniProt ID | FIBP_HUMAN | |
|---|---|---|
| UniProt AC | O43427 | |
| Protein Name | Acidic fibroblast growth factor intracellular-binding protein | |
| Gene Name | FIBP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 364 | |
| Subcellular Localization |
Nucleus. Endomembrane system Peripheral membrane protein. Also associated with cytoplasmic membranes, particularly of mitochondria. |
|
| Protein Description | May be involved in mitogenic function of FGF1. May mediate with IER2 FGF-signaling in the establishment of laterality in the embryo (By similarity).. | |
| Protein Sequence | MTSELDIFVGNTTLIDEDVYRLWLDGYSVTDAVALRVRSGILEQTGATAAVLQSDTMDHYRTFHMLERLLHAPPKLLHQLIFQIPPSRQALLIERYYAFDEAFVREVLGKKLSKGTKKDLDDISTKTGITLKSCRRQFDNFKRVFKVVEEMRGSLVDNIQQHFLLSDRLARDYAAIVFFANNRFETGKKKLQYLSFGDFAFCAELMIQNWTLGAVGEAPTDPDSQMDDMDMDLDKEFLQDLKELKVLVADKDLLDLHKSLVCTALRGKLGVFSEMEANFKNLSRGLVNVAAKLTHNKDVRDLFVDLVEKFVEPCRSDHWPLSDVRFFLNQYSASVHSLDGFRHQALWDRYMGTLRGCLLRLYHD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTSELDIFV ------CCCCCEEEE | 30.79 | 19369195 | |
| 2 | Acetylation | ------MTSELDIFV ------CCCCCEEEE | 30.79 | 19369195 | |
| 75 | Ubiquitination | RLLHAPPKLLHQLIF HHHCCCHHHHHHHHH | 63.72 | - | |
| 118 | Ubiquitination | KLSKGTKKDLDDIST HCCCCCCCCHHHCHH | 64.46 | - | |
| 124 | Phosphorylation | KKDLDDISTKTGITL CCCHHHCHHHCCCCH | 30.74 | 26074081 | |
| 125 | Phosphorylation | KDLDDISTKTGITLK CCHHHCHHHCCCCHH | 32.72 | 26074081 | |
| 126 | Ubiquitination | DLDDISTKTGITLKS CHHHCHHHCCCCHHH | 37.65 | 21906983 | |
| 126 (in isoform 1) | Ubiquitination | - | 37.65 | 21890473 | |
| 126 (in isoform 2) | Ubiquitination | - | 37.65 | 21890473 | |
| 127 | Phosphorylation | LDDISTKTGITLKSC HHHCHHHCCCCHHHH | 33.63 | 26074081 | |
| 130 | Phosphorylation | ISTKTGITLKSCRRQ CHHHCCCCHHHHHHH | 29.49 | 26074081 | |
| 132 | Ubiquitination | TKTGITLKSCRRQFD HHCCCCHHHHHHHHH | 38.57 | 29967540 | |
| 142 | Acetylation | RRQFDNFKRVFKVVE HHHHHHHHHHHHHHH | 54.64 | 25953088 | |
| 142 | Ubiquitination | RRQFDNFKRVFKVVE HHHHHHHHHHHHHHH | 54.64 | 24816145 | |
| 146 | Ubiquitination | DNFKRVFKVVEEMRG HHHHHHHHHHHHHHC | 42.38 | 24816145 | |
| 146 | Acetylation | DNFKRVFKVVEEMRG HHHHHHHHHHHHHHC | 42.38 | 25953088 | |
| 235 | Ubiquitination | DMDMDLDKEFLQDLK CCCCCCCHHHHHHHH | 58.63 | 22817900 | |
| 238 | Ubiquitination | MDLDKEFLQDLKELK CCCCHHHHHHHHHHC | 3.98 | 21890473 | |
| 238 (in isoform 2) | Ubiquitination | - | 3.98 | 21890473 | |
| 242 | Ubiquitination | KEFLQDLKELKVLVA HHHHHHHHHHCCEEE | 70.10 | 22817900 | |
| 244 | Ubiquitination | FLQDLKELKVLVADK HHHHHHHHCCEEECH | 4.43 | 21890473 | |
| 244 (in isoform 2) | Ubiquitination | - | 4.43 | 21890473 | |
| 245 (in isoform 1) | Ubiquitination | - | 34.32 | 21890473 | |
| 245 | Ubiquitination | LQDLKELKVLVADKD HHHHHHHCCEEECHH | 34.32 | 23000965 | |
| 251 (in isoform 1) | Ubiquitination | - | 40.30 | 21890473 | |
| 251 | Acetylation | LKVLVADKDLLDLHK HCCEEECHHHHHHHH | 40.30 | 25953088 | |
| 251 | Ubiquitination | LKVLVADKDLLDLHK HCCEEECHHHHHHHH | 40.30 | 23000965 | |
| 258 | Ubiquitination | KDLLDLHKSLVCTAL HHHHHHHHHHHHHHH | 53.43 | 23000965 | |
| 261 | Ubiquitination | LDLHKSLVCTALRGK HHHHHHHHHHHHHHC | 3.35 | 23000965 | |
| 268 | Ubiquitination | VCTALRGKLGVFSEM HHHHHHHCCCCCCHH | 35.32 | 23000965 | |
| 273 | Ubiquitination | RGKLGVFSEMEANFK HHCCCCCCHHHHHHC | 33.36 | 21963094 | |
| 273 (in isoform 2) | Ubiquitination | - | 33.36 | 21890473 | |
| 280 (in isoform 1) | Ubiquitination | - | 57.71 | 21890473 | |
| 280 | Ubiquitination | SEMEANFKNLSRGLV CHHHHHHCHHHHHHH | 57.71 | 21963094 | |
| 285 | Ubiquitination | NFKNLSRGLVNVAAK HHCHHHHHHHHHHHH | 30.51 | 29967540 | |
| 290 | Ubiquitination | SRGLVNVAAKLTHNK HHHHHHHHHHHHCCC | 8.15 | 29967540 | |
| 292 | Ubiquitination | GLVNVAAKLTHNKDV HHHHHHHHHHCCCCH | 44.15 | 29967540 | |
| 297 | Ubiquitination | AAKLTHNKDVRDLFV HHHHHCCCCHHHHHH | 50.42 | 29967540 | |
| 331 | Phosphorylation | VRFFLNQYSASVHSL HHHHHHHHCCCHHCC | 12.72 | 27732954 | |
| 332 | Phosphorylation | RFFLNQYSASVHSLD HHHHHHHCCCHHCCC | 12.33 | 27732954 | |
| 334 | Phosphorylation | FLNQYSASVHSLDGF HHHHHCCCHHCCCCC | 17.89 | 27732954 | |
| 337 | Phosphorylation | QYSASVHSLDGFRHQ HHCCCHHCCCCCHHH | 26.46 | 27732954 | |
| 353 | Phosphorylation | LWDRYMGTLRGCLLR HHHHHHHHHHHHHHH | 9.21 | 28060719 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FIBP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FIBP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FIBP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| C2CD5_HUMAN | C2CD5 | physical | 17353931 | |
| OGT1_HUMAN | OGT | physical | 17353931 | |
| IF6_HUMAN | EIF6 | physical | 17353931 | |
| GEMI4_HUMAN | GEMIN4 | physical | 17353931 | |
| AP4B1_HUMAN | AP4B1 | physical | 17353931 | |
| CLC2L_HUMAN | CLEC2L | physical | 17353931 | |
| MIF_HUMAN | MIF | physical | 17353931 | |
| A4_HUMAN | APP | physical | 21832049 | |
| C2CD5_HUMAN | C2CD5 | physical | 26186194 | |
| TMM94_HUMAN | KIAA0195 | physical | 26186194 | |
| CABL2_HUMAN | CABLES2 | physical | 26186194 | |
| CABL1_HUMAN | CABLES1 | physical | 26186194 | |
| CDK5_HUMAN | CDK5 | physical | 26186194 | |
| GRM1C_HUMAN | GRAMD1C | physical | 26186194 | |
| CDK5_HUMAN | CDK5 | physical | 28514442 | |
| C2CD5_HUMAN | C2CD5 | physical | 28514442 | |
| CABL2_HUMAN | CABLES2 | physical | 28514442 | |
| CABL1_HUMAN | CABLES1 | physical | 28514442 | |
| TMM94_HUMAN | KIAA0195 | physical | 28514442 | |
| GRM1C_HUMAN | GRAMD1C | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND MASSSPECTROMETRY. | |